Regulatory role of vHL/HIF-1α in hypoxia-induced VEGF production in hepatic stellate cells

Biochemical and Biophysical Research Communications

Volumn 317, Issue 2, 2004, Pages 358-362

  Wang, Yang Q ^a   Luk, John M ^a   Ikeda, Kazuo ^b   Man, Kwan ^a   Chu, Andrew C ^a   Kaneda, Kenji ^b   Fan, Sheung Tat ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

COX 2; HIF 1 ; Hypoxic T6 HSCs; VEGF; vHL

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDOMETACIN; NIMESULIDE; PROTEIN; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FIBROGENESIS; GENE EXPRESSION; HYPOXIA; LIVER CELL; LIVER INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; STELLATE CELL; TIMED DRUG RELEASE;

ANIMALS; CARRIER PROTEINS; CELL HYPOXIA; CELL LINE; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HEPATOCYTES; HOMEOSTASIS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INDOMETHACIN; ISOENZYMES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; SULFONAMIDES; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1842426689     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.03.050     Document Type: Article

References (30)

1. D. Li, S.L. Friedman, Hepatic stellate cells: morphology, function, and regulation, in: The Liver: Biology and Pathobiology, fourth ed., Raven Press, New York, 2001, pp. 455-468
2. Ankoma-sey V., Maitli M., Chang K.B., Lalaxar A., Donner D.B., Wong L., Warren R.S., Friedman S.L. Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing. Oncogene. 17(1):1998;115-121.
3. Mochida S., Ishikawa K., Toshima K., Inao M., Ikeda H., Mastsui A., Shibuya M., Fujiwara K. The mechanisms of hepatic sinusoidal endothelial cell regeneration: a possible communication system associated with vascular endothelial growth factor in liver cells. J. Gastroenterol. Hepatol. 13 Suppl. 1998;S1-S5.
4. Ishikawa K., Mochida S., Mashiba S., Inao M., Matsui A., Ikeda H., Ohno A., Shibuya M., Fujiwara K. Expressions of vascular endothelial growth factor in nonparenchymal as well as parenchymal cells in rat liver after necrosis. Biochem. Biophys. Res. Commun. 254:1999;587-593.
5. Jones M.K., Szabo I.L., Kawanaka H., Husain S.S., Tarnawski A.S. von Hippel-Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis. FASEB J. 16:2002;264-266.
6. Corpechot C., Barbu V., Wendum D., Kinnman N., Rey C., Poupon R., Housset C., Rosmorduc O. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology. 35(5):2002;1010-1012.
7. Ankoma-Sey V., Wang Y., Dai Z. Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells. Hepatology. 31:2000;141-148.
8. Olaso E., Salado C., Egilegor E., Gutierrez V., Santisteban A., Sancho-Bru P., Friedman S.L., Vidal-Vanaclocha F. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis. Hepatology. 37:2003;674-685.
9. Yamamoto H., Kondo N., Nakamori S., Nagano H., Wakasa K., Sugita Y., Chang-De J., Kobayashi S., Damdinsuren B., Dono K., Umeshita K., Sekimoto N., Sakon N., Natsuura N., Nonden N. JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis. Gastroenterology. 125(2):2003;556-571.
10. Wang Y.Q., Ikeda K., Ikebe T., Hirakawa K., Nakatani K., Kawada N., Kaneda K. Inhibition of hepatic stellate cell proliferation and activation by the semisynthetic analogue of fumagillin TNP-470 in rats. Hepatology. 32:2000;980-989.
11. Yoshiji H., Kuriyama S., Yoshii J., Ikenaka Y., Noguchi R., Hicklin D.J., Wu Y., Yanase K., Namisaki T., Yamazaki M., Tsujinoue H., Imazu H., Masaki T., Fukui H. Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis. Gut. 52(9):2003;1347-1354.
12. Graupera M., Carlia-pagan J.C., Abraldes J.G., Peralta G., Bragulat M., Corominola H., Bosch J., Rodes J. Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers. Hepatology. 37:2003;172-181.
13. Vogel S., Piantedosi R., Frank J., Lalazar A., Rockey D.C., Friedman S.L., Blaner W.S. An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J. Lipid Res. 41:2000;882-893.
14. Wong B.W., Luk J.M., Ng I.O., Hu M.Y., Lang K.D., Fan S.T. Identification of liver-intestine cadherin in hepatocellular carcinoma - a potential disease marker. Biochem. Biophys. Res. Commun. 311:2003;618-624.
15. Luk J.M., Mok B.W., Shum C.K., Yeung W.S., Tam P.C., Tse J.Y., Chow J.F., Woo J., Kam K., Lee K.F. Identification of novel genes expressed during spermatogenesis in stage-synchronized rat testes by differential display. Biochem. Biophys. Res. Commun. 307:2003;782-790.
16. Wang G.L., Jiang B.H., Rue E.A., Semenza G.L. Hypoxia-inducible factor 1 is a basic-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA. 92:1995;5510-5514.
17. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature. 407:2000;249-257.
18. William G., Kaelin J.R. Cancer: many vessels, faulty gene. Nature. 399:1999;203-204.
19. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., Wykoff C.C., Pugh C.W., Maher E.R., Ratcliffe P.J. The tumour suppressor protein vHL targets hypoxic-inducible factors for oxygen-dependent proteolysis. Nature. 399:1999;271-275.
20. Pal S., Claffey K.P., Dvorak H.F., Mukhopadhyay D. The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways. J. Biol. Chem. 272:1997;27509-27512.
21. Kamura T., Sato S., Iwai K., Czyzyk-Krzeska M., Conaway R.C., Conaway J.W. Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc. Natl. Acad. Sci. USA. 97:2000;10430-10435.
22. Kimura H., Weisz A., Ogura T., Hitomi Y., Kurashima Y., Hashimoto K., D'Acquisto F., Makuuchi M., Esumi H. Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J. Biol. Chem. 276:2001;2292-2298.
23. Levy A.P., Levy N.S., Wegner S., Goldberg M.A. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270:1995;13333-13340.
24. Goldberg M.A. Regulation of the erythropoietin gene; evidence that the oxygen sensor is a heme protein. Science. 242:1988;1412-1415.
25. Wang G.L. Desfrrioxamine induces erythropoietin gene expression and hypoxia-inducible factor1 DNA-binding activity; implications for models of hypoxia signal transduction. Blood. 82:1993;3610-3615.
26. Chen D., Li M., Luo J., Gu W. Direct interaction between HIF-1α and Mdm2 modulate p53 function. J. Biol. Chem. 278:2001;13595-13598.
27. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., Tian Y.M., Masson N., Hamilton D.L., Jaakkola P., Barstead R., Hodgkin J., Maxwell P.H., Pugh C.W., Schofield C.J., Ratcliffe P.J., Elegans C. EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 107:2001;43-54.
28. Blouin C.C., Pagé E.L., Soucy G.M., Richard D.E. Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor-1. Blood. 103:2004;1124-1130.
29. Shmueli A., Oren M. Regulation of p53 by Mdm2: fate is in the numbers. Mol. Cell. 13(1):2004;4-5.
30. Graeber T.G. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14:1994;6264-6277.